From: Characterizing the relationship between health utility and renal function after kidney transplantation in UK and US: a cross-sectional study
CKD stage 1–2 (eGFR ≥60)
CKD stage 3 (60 > eGFR ≥ 30)
CKD stage 4 (30 > eGFR ≥ 15)
CKD stage 5 (eGFR<15)
Sample
Mean EQ-5Dindex
P-value
US
0.83
0.85
0.78
0.72
0.04
UK
0.64
0.58
0.49
0.28
0.02